Despite the high levels of comorbidity between post-traumatic stress disorder (PTSD) and sleep disturbance, little research has examined the predictors of insomnia and nightmares in this population. The current study tested both PTSD-specific (i.e. PTSD symptoms, comorbid anxiety and depression, nightmares and fear of sleep) and insomnia-specific (i.e. dysfunctional beliefs about sleep, insomnia-related safety behaviours and daily stressors) predictors of sleep quality, efficiency and nightmares in a sample of 30 individuals with PTSD. Participants participated in ecological momentary assessment to determine how daily changes in PTSD-and insomnia-related factors lead to changes in sleep. Multi-level modelling analyses indicated that, after accounting for baseline PTSD symptom severity, PTSD-specific factors were associated with insomnia symptoms, but insomnia-specific factors were not. Only daytime PTSD symptoms and fear of sleep predicted nightmares. Both sleep-and PTSD-related factors play a role in maintaining insomnia among those with PTSD, while nightmares seem to be linked more closely with only PTSD-related factors.
IN TROD UCTI ON
The comorbidity between post-traumatic stress disorder (PTSD) and sleep difficulties has been well documented throughout the research literature, with sleep disturbances being named the 'hallmark' PTSD symptom as early as 1989 (Ross et al., 1989) . Despite this, relatively little research has examined the causes of sleep problems among individuals with PTSD. Although sleep disturbances were conceptualized historically as a product of PTSD itself, they tend to persist even after PTSD is treated successfully , suggesting a need for investigation into the factors apart from PTSD symptoms that cause and maintain sleep disturbance among those with PTSD.
Typically, sleep disturbances among those with PTSD are thought to be triggered and maintained initially by PTSD symptoms. For example, many studies have found a link between PTSD symptom severity and insomnia symptoms or nightmares (Short et al., 2014) . Relatedly, trauma-related nightmares can cause or exacerbate insomnia symptoms Gellis et al., 2010; Krakow et al., 2000) . However, many prior studies have relied upon crosssectional examinations, despite the significant day-to-day variation in symptoms many with PTSD experience (Possemato et al., 2012) . Assessing daily levels of PTSD could inform us as to whether increased PTSD symptoms during the day lead to poorer sleep that night. Furthermore, those with PTSD may begin to fear sleep due to its association with nightmares (Pruiksma et al., 2014) , which could further disrupt sleep onset. We considered fear of sleep a PTSDrelated variable rather than an insomnia-related one due to its specificity with PTSD-related insomnia (i.e. we would not expect an individual with insomnia disorder without PTSD to fear sleep per se, as we might expect individuals with PTSD to do so). Despite the potential importance of fear of sleep in insomnia symptoms, it has not been examined as a predictor of insomnia symptoms and nightmares among a clinical sample of those with PTSD. Finally, depression is a common comorbidity with PTSD, and has also been linked to poor sleep and nightmares Gellis et al., 2010) , but has only been examined as cross-sectional correlates of sleep disturbance.
In addition to these PTSD-specific pathways to sleep disturbance, it is commonly believed that insomnia develops its own maintenance factors over time (Talbot et al., 2014) . For example, individuals with PTSD-related sleep disturbance probably develop dysfunctional beliefs about sleep (DBAS), which serve to amplify distress related to insomnia and increase trouble with sleep onset and maintenance (Morin et al., 2007) . Furthermore, it is likely that individuals begin to engage in insomnia-related safety behaviours (e.g. going to bed early to allow enough time to fall asleep, sleeping in if one has difficulty falling asleep), which are used to cope with the symptoms of insomnia, but paradoxically increase difficulty falling asleep. Theoretically, maintenance factors such as these cause insomnia to persist regardless of PTSD status . The role of these insomnia-specific maintenance factors is supported further by research showing that cognitive-behavioural therapy for insomnia (CBT-I), which targets these maintenance factors, is effective in treating insomnia among those with PTSD without modifications and with only small effects on PTSD symptoms themselves (Talbot et al., 2014) . However, no prior research has tested whether insomnia-specific factors play a role in sleep disturbances among those with PTSD.
Overall, current models of sleep disturbance in PTSD emphasize both PTSD-related factors, as well as insomniaspecific factors in sleep disturbances among those with PTSD. It is important to note that this is a somewhat artificial distinction, as insomnia and nightmares are symptoms of PTSD and thus, by definition, PTSD-related. Despite this, we defined PTSD-related factors as those unique to those with PTSD and not insomnia disorder alone, while insomniarelated factors were those expected to be shared between individuals with insomnia disorder alone, as well as those with PTSD and comorbid insomnia disorder. However, research to date has neglected to examine both of these pathways to sleep disturbance among those with PTSD.
The current study was designed to address this gap in the current literature by testing PTSD-and insomnia-related predictors of insomnia symptoms (i.e. poor sleep quality and efficiency) and nightmares among a clinical sample of those with PTSD utilizing an ecological momentary assessment (EMA) design. This allowed us to investigate prospectively factors that maintain poor sleep and nightmares in an ecologically valid setting among those with PTSD. This design also is valuable considering that individuals with PTSD experience varying levels of PTSD symptoms on a daily basis (Possemato et al., 2012) , as well as significant variability in their sleep on a nightly basis, even compared to those with insomnia disorder (Straus et al., 2015) . We aimed to both replicate prior research finding that PTSD-related factors (i.e. PTSD symptom severity, anxiety, depression, nightmares and fear of sleep) predict sleep disturbances, and expand upon it by using an EMA design and incorporating insomnia-related factors (e.g. DBAS, insomnia-related safety behaviours). Based on previous empirical research as well as theoretical conceptualizations of sleep disturbance among those with PTSD, we hypothesized that (1) baseline and daily PTSD-related factors (PTSD, anxiety, depression, fear of sleep) would predict poor sleep quality and efficiency and nightmares during the EMA period above and beyond baseline PTSD symptoms; and (2) baseline insomnia-related factors (DBAS, insomnia-related safety behaviours) would predict poor sleep quality and efficiency, after accounting for baseline PTSD symptoms.
METH OD Participants
Participants consisted of 30 individuals recruited from the local community (n = 24, 77.4%) and from the university's undergraduate student research pool (n = 6, 19.4%). All individuals were required to be at least 18 years of age, have a diagnosis of PTSD as assessed by clinical interview and own a mobile phone with access to the internet. Exclusion criteria included being diagnosed with a psychotic disorder unstable on psychiatric medication and diagnosis of a severe substance use disorder. Ages of participants ranged from 18 to 60 years [mean = 38.03, standard deviation (SD) = 5.14], and the gender majority was female (61.3%). The sample identified predominantly as white (64.5%), followed by black (29.0%) and American Indian/Alaskan Native (3.2%). All participants met criteria for a current PTSD diagnosis. Distribution of most bothersome experienced trauma according to individuals' self-report on the PDS include: sexual assault by someone you know (33.3%), non-sexual assault by someone you know (13.3%), other (e.g. witnessing a death, mass grave sites, 13.3%), serious accident (10.0%), sexual assault by a stranger (10.0%), combat (6.7%), imprisonment (6.7%) and non-sexual assault by a stranger (3.3%), while one participant did not select a most bothersome event (3.3%). With regard to comorbid psychiatric conditions, 93.3% of the sample met criteria for at least one condition, with 80% meeting for a comorbid anxiety disorder, 73.3% met for a mood disorder, 26.7% met for an obsessive compulsive or related disorder, 13.3% met for a substance use disorder and 6.7% met for an eating disorder. These percentages include any comorbid disorder and thus add up to greater than 100%.
Procedure
Participants were recruited through advertisements in print and broadcast media or the university's undergraduate research pool. Those who were deemed eligible after the screening process were scheduled for a baseline appointment. All participants provided written informed consent and all procedures were approved by the university's institutional review board.
Participants reported to the laboratory for baseline, during which they completed a clinical interview and self-report measures and were instructed on how to complete the EMA period. Specifically, a research assistant collected information about the participants' habitual sleep and wake times, ª 2017 European Sleep Research Society which were used to create a quasi-random text message schedule for their EMA period. Next, the research assistant worked with the participant to complete a practice link on the participants' mobile phone to ensure that the participant understood how to respond to their surveys. After this, participants were dismissed and asked to call the laboratory with questions.
During the next 8 days (the EMA period), participants received four text messages per day sent on an evenly spaced quasi-random schedule according to their selfreported sleep schedule. As such, each participants' schedule of assessments varied. Text messages were sent automatically through Google Voice. Participants received one reminder text if they did not complete their assessment within 30 min. Furthermore, participants were contacted via telephone if they missed 2 full days of EMAs to determine whether there were any technical problems.
At the end of the EMA period, participants received monetary and/or course credit compensation. Participants received $25 or two to three units of course credit, regardless of how many EMA assessments they completed. If they completed at least 75% of their assessments, which 73.9% of participants did, they received a bonus of $10.
Measures

Baseline
Structured Clinical Interview for DSM-5 (SCID). The SCID is a widely administered and well-validated semi-structured interview designed to assess the presence of psychiatric conditions (First et al., 2015) . We used the SCID interview to determine PTSD diagnosis, and therefore eligibility, as well as the presence of comorbid diagnoses. The SCID was administered by trained clinical psychology doctoral students and reviewed by a licensed clinical psychologist. Agreement between interviewers for a random sample of SCIDs from our laboratory resulted in high inter-rater agreement (i.e. more than 80% with a kappa value of 0.86, n = 20; Schmidt et al., 2016) .
PTSD Checklist (PCL-5).
The PCL-5 is a well-validated self-report measure of PTSD symptoms reflecting DSM-5 symptoms of PTSD (US Department of Veterans Affairs, 2016; Weathers et al., 1993) . Sleep items were removed for all analyses, but the full mean of the PCL-5 was reported. The PCL-5 demonstrated excellent internal consistency in the present study (a = 0.91).
Insomnia Severity Index (ISI). The ISI is a brief seven-item self-report questionnaire assessing insomnia symptoms and severity (Morin et al., 2011) . The ISI has shown evidence of excellent psychometric properties (Morin et al., 2011) , and demonstrated excellent internal consistency in the present study (a = 0.90).
Disturbing Dream and Nightmare Severity Index (DDNSI). The DDNSI assesses the frequency, severity and intensity of nightmare complaints (Krakow, 2006 ). In the current study, the DDNSI demonstrated good internal consistency (a = 0.83).
Beck Anxiety Inventory (BAI).
The BAI is a 21-item selfreport questionnaire assessing symptoms of anxiety (Beck and Steer, 1993) . The BAI has shown evidence of good internal consistency, test-retest reliability and construct validity (Beck and Steer, 1993 ). In the current study, internal consistency was excellent (a = 0.92).
Beck Depression Inventory-II (BDI-II).
The BDI-II is a 21-item self-report questionnaire assessing the presence of depressive symptoms (Beck et al., 1988) . The BDI-II has demonstrated good psychometric properties, such as strong internal consistency and good test-retest reliability (Beck et al., 1988) . Internal consistency in the present sample was excellent (a = 0.92).
Fear of Sleep Inventory (FOSI).
The FOSI is a 23-item selfreport questionnaire designed to assess fear of sleep related to PTSD (Pruiksma et al., 2014) . Specifically, the FOSI measures avoidance and dread of nightmares or reexperiencing, fear of loss of vigilance and night-time vigilant behaviours. Prior research has suggested the FOSI possesses excellent internal consistency as well as temporal stability (Pruiksma et al., 2014 ). In the current study, the FOSI also demonstrated excellent internal consistency (a = 0.94).
Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS).
The DBAS is a 16-item self-report measure designed to evaluate a subset of sleep related cognitions, including misattribution or amplification of insomnia consequences, diminished perception of control and predictability of sleep, unrealistic sleep expectations, misconceptions about insomnia causes and faulty beliefs about sleeppromoting practices. The DBAS has demonstrated adequate psychometric properties, as evidenced by excellent internal consistency (in the current study, a = 0.90) and adequate convergent and discriminant validity (Morin et al., 2007) .
Sleep-Related Behaviors Questionnaire (SRBQ).
The SRBQ is a 32-item self-report assessment of insomniarelated safety behaviours (Ree and Harvey, 2004) . Participants are instructed to rate how often they engage in a list of behaviours (e.g. 'I work hard to conserve energy'; 'I take herbal remedies to aid sleep') to cope with tiredness or to improve sleep. Prior research indicated the SRBQ has good internal consistency and the ability to discriminate normal sleepers from those with insomnia (Ree and Harvey, 2004 ). In the current study, the SRBQ demonstrated good internal consistency (a = 0.88).
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Ecological momentary assessment PTSD symptoms. Post-traumatic stress disorder symptoms were assessed at each EMA time-point. Individuals rated symptoms they had been experiencing since their last assessment. Ten items from the PCL-5 assessed these symptoms, with instructions modified to assess current symptoms, consistent with prior EMA research (Possemato et al., 2012) . We selected two to three items per symptom cluster based on items loading most strongly onto each PTSD symptom cluster in factor analytical research (King et al., 1998) . Sleep items of the PCL-5 were excluded. Items included the following symptoms: intrusions; very upset when reminded of trauma; physical reactions when reminded of the trauma; avoiding internal reminders; avoiding external reminders; feeling distant or cut off from others; anhedonia; difficulty concentrating; watchfulness; and easily startled. Internal consistency for the abbreviated PCL-5 was good to excellent in the present study (session-level a = 0.80, daylevel a = 0.91, person-level a = 0.93).
Anxiety. Anxiety was assessed at each time-point using three items drawn from the State/Trait Anxiety Inventory (Spielberger, 2010) . We chose one to two items loading most strongly onto the factors according to factor analytical research (Vigneau and Cormier, 2008) : worried, tense, upset. Our assessment of self-reported anxiety demonstrated at least adequate internal consistency (session-level a = 0.70, day-level a = 0.91, person-level a = 0.90).
Stressors. Stressors were assessed by asking participants if they experienced 'anything upsetting or stressful' since their last EMA assessment. Participants responded by answering 'yes' or 'no'. Responses were summed per day to create a total number of stressors experienced each day.
Sleep disturbances. Each morning, items assessed sleep disturbance from the prior night. Sleep efficiency was calculated by dividing the total sleep time by hours in bed and is expressed as a percentage. Sleep quality was assessed using the PSQI's subjective sleep quality component (Buysse et al., 1989) . Finally, nightmares were assessed using the trauma-related nightmare item from the PSQI's PTSD addendum. With regard to sleep quality and nightmares, higher scores represent worse sleep. However, sleep efficiency is expressed as a percentage; therefore, higher scores reflect better sleep. Unconditional models of sleep efficiency, sleep quality and nightmares indicated significant levels of variance at the day and individual level, suggesting there was individual variability in these symptoms across days.
Data analytical plan
Multi-level modelling was used due to its ability to take into account nested data and missing data better than classical analyses used to analyse EMA studies. Analyses were conducted using MPlus version 7.4 with full information maximum likelihood estimation using the robust estimator (Muth en and Muth en, 1998-2012) . The models consisted of three levels with random effects: sessions (or time-points each day-i.e. waking, morning, afternoon, night) nested within days nested within individuals. Dependent variables were sleep disturbances assessed at session 1 each day. Independent day-level variables were aggregate levels of PTSD symptoms, anxiety and stressors assessed the prior day (i.e. all daily variables were assessed the day before the morning in which participants rated their sleep. As such, these variables are from during the day predicting that night's sleep). However, sleep predictors are from the same night. Additionally, baseline variables (e.g. DBAS, fear of sleep, etc.) were independent variables in relevant models. We refer to all variables drawn from the EMA period as 'daily' (e.g. daily anxiety), and all drawn from the baseline as 'baseline' (e.g. baseline anxiety).
Throughout the Results section, unstandardized estimates are reported (Hox, 2010) . Currently, there is no consensus on how to best report effect size in multi-level modelling (Singer and Willet, 2003) . However, we calculated proportion reduction in variance to address effect size (Peugh, 2010) . Essentially, this method compares the residual variance from the unconditional model (not including the independent variable of interest) to the residual variance from the model that does include the independent variable of interest. PRVs are reported throughout for all significant predictors. For analyses with day-level variables, PRVs are reported as proportion reduction in within-level variance, and for analyses with baseline variables, PRVs are reported as proportion reduction in between-level variance.
RESULTS
Preliminary analyses
First, data were screened to confirm accurate data entry, assess for outliers and evaluate skewness and kurtosis. Evaluation of data ranges confirmed that most of responses were entered correctly. In three cases, participants entered numbers that were logically impossible (e.g. sleeping for more than 300 h in one night). Consistent with recommendations of Bell and Malacova (2004) , these responses were omitted. We also evaluated the data for outliers and analyses indicated there were none that could potentially influence the models. Regarding missing data, 80.0% of the possible EMAs were completed by participants. No participants were excluded due to missing data, as multi-level modelling uses full information maximum likelihood to include all participants regardless of missing data presence, and because dropping participants with missing data can introduce bias (Schafer and Graham, 2002 Krakow, 2006) . Anxiety (mean = 025.86) and depression (mean = 28.14) were in the moderate range (20-28 and 17-29, respectively; Beck and Steer, 1993; Beck et al., 1988) . DBAS means (6.28) surpassed the recommended clinical cut-off of 3.8 (Carney et al., 2010) . Insomnia-related behaviour scores (mean = 58.72) were similar to prior research among a clinical sample of individuals with insomnia (Ree and Harvey, 2004) . Correlations were in the expected directions, although non-significant associations were found in some analyses with nightmares. We also examined key EMA variables' means and SDs (Table 2 ). There was a significant effect of day, such that PTSD symptoms decreased as the EMA period went on [b = À0.05, standard error (SE) = 0.02, P = 0.001]. However, there was no significant effect of time of day on PTSD symptoms (b = 0.46, SE = 056, P = 0.41).
Primary analyses
Associations between PTSD-related factors and EMAassessed sleep disturbance Separate models revealed that elevated baseline PTSD, anxiety, depression, fear of sleep, daily PTSD and daily anxiety predicted poorer sleep quality significantly during the EMA period (Table 3) . Elevated baseline PTSD, anxiety, depression, fear of sleep and daily nightmares each predicted reduced sleep efficiency during the EMA period. Finally, baseline PTSD, daily PTSD and fear of sleep predicted increased nightmares significantly. We then examined the contributions of significant PTSD-related variables after covarying for baseline PTSD symptoms (Table 4) . In separate models, after covarying for PTSD, depression (PRV = 36.4%), fear of sleep (PRV = 39.8%) and daily anxiety (PRV = 7.0%) predicted poorer sleep quality. Elevated baseline anxiety and depression, and daily nightmares continued to predict poorer sleep efficiency significantly. Baseline fear of sleep (PRV = 14.8%) and daily PTSD (PRV < 1.0%) continued to predict nightmares after accounting for baseline PTSD.
Associations between baseline insomnia-related factors and EMA-assessed sleep disturbance
Dysfunctional beliefs about sleep, insomnia-related behaviours and daily worsened sleep efficiency each significantly predicted poorer sleep quality, while daily stressors did not (Table 3) . Insomnia-related behaviours predicted poorer sleep efficiency significantly, although DBAS and daily stressors did not. No insomnia-related variables predicted nightmares during the EMA period. After covarying for PTSD symptoms (Table 4) , poor daily sleep efficiency predicted poorer self-reported sleep quality significantly (PRV = 32.6%), but no other insomnia-related predictors predicted insomnia symptoms or nightmares significantly.
DISCUSSION
The current study used EMA to test the role of PTSD-and insomnia-related factors in predicting insomnia symptoms and nightmares among those with PTSD. Furthermore, the use of daily variables allowed us to determine whether predictors temporally preceded a poor night's sleep. First, results indicated that after accounting for overall PTSD symptom severity, daily nightmares predicted decreased sleep efficiency significantly. This is consistent with prior cross-sectional findings Gellis et al., 2010) , as well as findings that trauma-related nightmares are associated with increased wake after sleep onset in laboratory studies of sleep (Woodward et al., 2000b) . However, our PTSD, post-traumatic stress disorder; SD, standard deviation; n = 0.29. *P < 0.05; **P < 0.01; ***P < 0.001.
ª 2017 European Sleep Research Society findings expand upon these by indicating that daily nightmares are associated with poorer sleep efficiency on a nightly basis in individuals' natural sleep environment. In turn, poor daily sleep efficiency was associated with poor sleep quality. Relatedly, our findings indicate that baseline fear of sleep was associated with poor sleep quality, which is consistent with cross-sectional research among traumaexposed individuals (Pruiksma et al., 2014) . In sum, this set of findings is consistent with the idea that PTSD-specific factors (i.e. nightmares, fear of sleep) cause insomnia symptoms, and suggest that daily variations in these factors are associated with variations in insomnia symptoms.
Secondly, results indicated that higher levels of baseline depression and daily anxiety predicted poor daily sleep quality and efficiency. This is consistent with prior crosssectional research Gellis et al., 2010) , and expand upon it by showing that daily increases in anxiety temporally precede and thus may lead to poorer sleep efficiency. This is consistent with the view that anxious arousal during the day leads to difficulties with sleep onset and maintenance throughout the night (Woodward et al., 2000a) . Overall, comorbid symptoms of depression and anxiety may exacerbate insomnia symptoms among those with PTSD. Indeed, baseline depression severity was the only factor associated consistently across both insomnia measures, suggesting that it plays an important role in maintaining insomnia symptoms.
Thirdly, regarding insomnia-related factors, baseline DBAS and insomnia-related safety behaviours each predicted poor daily sleep quality significantly, while only baseline insomniarelated safety behaviours predicted poor daily sleep efficiency significantly. This is consistent with conceptualizations of insomnia among those with PTSD highlighting insomniaspecific factors in maintaining insomnia over time, despite PTSD symptom status. However, inconsistent with hypotheses, after covarying for baseline PTSD symptoms, baseline DBAS and insomnia-related safety behaviours were no longer associated significantly with either poor sleep quality of efficiency. This could be because the measurement confounded insomnia-related safety behaviours and PTSD itself. For example, some items (e.g. 'I stay in the background in social situations', which are intended to refer to the fact that some individuals may avoid social situations to disguise their fatigue or to conserve energy), could be due to avoidance related to PTSD (e.g. staying in the background in social situations could be due to safety-related concerns) rather than an insomnia-related safety behaviour. Alternatively, it is possible that PTSD and these insomnia-related factors are more intertwined than thought previously. For example, individuals with PTSD who fear intrusive memories may begin to believe that they have lost control of their mental functioning, thus believing that they will lose control of their ability to fall asleep (a DBAS). Further research is needed to investigate the development of DBAS and insomnia-related safety behaviours prospectively among those with PTSD, and how they maintain insomnia symptoms.
Fourthly, regarding nightmares, only baseline fear of sleep and daily PTSD symptoms predicted nightmares significantly. This is consistent with prior research noting that only elevated PTSD symptoms predicted increased nightmares (Neylan et al., 1998) , and expands upon it by indicating that increased PTSD symptoms temporally precede nightmares. It is interesting that baseline fear of sleep predicted later nightmares, raising the idea that fear of sleep and nightmares could share a bidirectional relationship with one another. However, this hypothesis needs further testing, ideally with a prospective study initiating prior to the development of PTSD and traumatic nightmares. Inconsistent with hypothesis, no (Schredl, 2003) . The lack of association between anxiety and nightmares in our sample could be because of the apparent close link between PTSD symptoms specifically (rather than general anxiety or depression) and nightmares in this population. The current findings also have clinical implications for treating insomnia among those with PTSD. Results suggest a need for clinicians to consider factors beyond those that are targeted traditionally through CBT-I. Although CBT-I reduces insomnia for those with PTSD, many treatment completers do not achieve 'good sleeper' status (Talbot et al., 2014) . This suggests that there is room for improvement in treating insomnia among this population. Specifically, clinicians could consider assessing and targeting PTSD-specific factors, such as nightmares and fear of sleep, when treating PTSDrelated insomnia. Treatments could then target nightmares themselves, as well as distorted beliefs about the likelihood of experiencing nightmares, and the dangerousness of nightmares and the loss of control associated with falling asleep. Although many clinicians may integrate such discussions, prior research on CBT-I in PTSD has avoided them intentionally (Talbot et al., 2014) , so it is possible that integrating these PTSD-specific factors could enhance CBT-I in this population. PTSD, post-traumatic stress disorder; SE, standard error; n = 30. *P < 0.05; **P < 0.01; ***P < 0.001. All analyses are from separate models. PTSD, post-traumatic stress disorder; SE, standard error; n = 30. *P < 0.05; **P < 0.01; ***P < 0.001. All analyses are from separate models.
Results of the current study should be considered in the context of its limitations and opportunities for future research. First, we did not include an objective measure of sleep, such as actigraphy. Although research has suggested that selfreported assessments of sleep are typically fairly consistent with objective measures (Zinkhan et al., 2014) , actigraphy could validate self-report and provide additional information. Secondly, some of our predictors of poor sleep (e.g. insomnia-related safety behaviours, DBAS) were not assessed daily. Although DBAS would not be expected to change significantly over the course of 8 days, insomniarelated safety behaviours could be measured on a daily basis to potentially provide more accurate information regarding their association with nightly sleep. Thirdly and fourthly, all participants had a diagnosis of PTSD, but they differed in terms of the chronicity of their diagnosis, and the sample size was relatively small. This is consistent with other EMA studies with clinical samples, but results may not generalize to all individuals diagnosed with PTSD. Fifthly, baseline PTSD symptoms were assessed via self-report (i.e. PCL-5) versus a clinical interview such as the Clinician-Administered PTSD Scale (CAPS; Blake et al., 1995) . Sixthly, although the majority of the variables in the EMA temporally preceded that night's sleep, the insomnia-related variables were from the same night. This precludes any causal inferences.
Despite these limitations, the current study adds valuable new information to the literature on sleep disturbances among those with PTSD. Specifically, our study is the first to test prospectively whether theoretically relevant factors predict insomnia symptoms among those with PTSD. Results highlight the importance of PTSD-specific pathways to insomnia, including nightmares and fear of sleep. However, findings also suggest that DBAS and insomnia-related safety behaviours are important predictors of poor sleep in this population, although potentially linked more closely to PTSD symptoms than thought previously. Finally, the results indicate that only PTSD symptoms and fear of sleep predict daily experience of nightmares. In sum, results underscore the complexity of the aetiology of sleep disturbance in PTSD, and suggest new directions for improving our treatment of insomnia in PTSD by considering the role of both PTSD-and insomnia-specific factors.
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